Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03270670 · ClinicalTrials.gov registry record
Olympus - 19-gauge Needle
A clinical trial of Lung Cancer, sponsored by Duke University.
- Completed
- Registry status
- 50
- Enrollment target
- 2
- Study locations
NCT03270670: Completed study of Lung Cancer, sponsored by Duke University.
NCT03270670 is a study of Lung Cancer that has completed, run by Duke University. The registered enrollment target is 50 participants, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (95% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03270670, a study of Lung Cancer, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to test whether the 19-gauge needle can collect more tissue and get better sampling during a bronchoscopy procedure.
Primary Outcome
Descriptive statistics will be used to calculate the success rate of the procedure in successful performance of molecular marker testing
Conditions Studied
Study Locations (2)
Missouri
- Washington University in St. Louis - St Louis
North Carolina
- Duke Medical Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2017-08-21 |
| Est. Completion | 2019-01-30 |
What the finished NCT03270670 record still lists
NCT03270670 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT03270670 reports a single indexed study location in Missouri, North Carolina.
Frequently Asked Questions
What is clinical trial NCT03270670 about?
NCT03270670 is a clinical study titled "Olympus - 19-gauge Needle". The purpose of this study is to test whether the 19-gauge needle can collect more tissue and get better sampling during a bronchoscopy procedure.
What is the current status of trial NCT03270670?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2017-08-21. Estimated completion is 2019-01-30.
What conditions does trial NCT03270670 study?
This clinical trial studies the following conditions: Lung Cancer.
Who is sponsoring clinical trial NCT03270670?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03270670 being conducted?
This trial has 2 study locations across Missouri, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03270670's enrollment target sits among peer trials
50 264th of 409 higher than 141 of 409 other Lung Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Health Opportunities and Promoters of Equitable Screening for Lung Cancer
RECRUITING
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI